Federal award
ROCHE DIAGNOSTICS CORPORATION
W91YTZ24P0015
Contract
Obligated and Ceiling
- Obligated (net)
- $382,082.97
- Ceiling (potential value, not spending)
- $652,378.12
- Current value
- $382,082.97
- Gross positive obligations
- $382,082.97
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ24P0015
- Award type code
- B
- Actions
- 9 · Jan 29, 2024 to Jun 10, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 10, 2026 | FY2026 | P00008 | B | $3,173.37 | — |
| Apr 10, 2026 | FY2026 | P00007 | B | $1,030.35 | — |
| Mar 11, 2026 | FY2026 | P00006 | G | $129,272.40 | — |
| Jan 22, 2026 | FY2026 | P00005 | B | $1,248.33 | — |
| Apr 1, 2025 | FY2025 | P00004 | C | $125,506.92 | — |
| Mar 12, 2025 | FY2025 | P00003 | G | $0.00 | — |
| Jan 16, 2025 | FY2025 | P00002 | M | $0.00 | — |
| Jun 3, 2024 | FY2024 | P00001 | C | $121,851.60 | — |
| Jan 29, 2024 | FY2024 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.